Cargando…

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020

Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) and Crohn’s disease (CD). Since 1950, the number of patients with IBD in Japan has been increasing. The etiology of IBD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakase, Hiroshi, Uchino, Motoi, Shinzaki, Shinichiro, Matsuura, Minoru, Matsuoka, Katsuyoshi, Kobayashi, Taku, Saruta, Masayuki, Hirai, Fumihito, Hata, Keisuke, Hiraoka, Sakiko, Esaki, Motohiro, Sugimoto, Ken, Fuji, Toshimitsu, Watanabe, Kenji, Nakamura, Shiro, Inoue, Nagamu, Itoh, Toshiyuki, Naganuma, Makoto, Hisamatsu, Tadakazu, Watanabe, Mamoru, Miwa, Hiroto, Enomoto, Nobuyuki, Shimosegawa, Tooru, Koike, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137635/ https://www.ncbi.nlm.nih.gov/pubmed/33885977 http://dx.doi.org/10.1007/s00535-021-01784-1

Ejemplares similares

Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
por: Nakase, Hiroshi, et al.
Publicado: (2023)

A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study
por: Saito, Daisuke, et al.
Publicado: (2023)

Evidence-based clinical practice guidelines for inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
por: Hibi, Toshifumi, et al.
Publicado: (2023)

A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan
por: Ando, Katsuyoshi, et al.
Publicado: (2021)

Diagnosis and management of intestinal Behçet’s disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2014)

EP1269: INTERIM ANALYSIS OF A MULTICENTER REGISTRY STUDY OF COVID-19 INFECTED PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN (J-COSMOS).
por: Hayashi, Yuki, et al.
Publicado: (2022)

Tu1546: JAPAN PROSPECTIVE MULTICENTER STUDY FOR OPTIMIZATION OF COVID-19 VACCINATIONS BASED ON THE IMMUNE RESPONSE AND SAFETY PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: INTERIM ANALYSES
por: Watanabe, Kenji, et al.
Publicado: (2022)

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
por: Hisamatsu, Tadakazu, et al.
Publicado: (2018)

Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
por: Yamazaki, Hajime, et al.
Publicado: (2019)

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)
por: Nakase, Hiroshi, et al.
Publicado: (2022)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation
por: Kishi, Masahiro, et al.
Publicado: (2022)

Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
por: Nakase, Hiroshi, et al.
Publicado: (2023)

Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
por: Watanabe, Kenji, et al.
Publicado: (2020)

Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy
por: Hata, Keisuke, et al.
Publicado: (2020)

Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
por: Naganuma, Makoto, et al.
Publicado: (2017)

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study
por: Shinzaki, Shinichiro, et al.
Publicado: (2021)

Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
por: Yamamoto, Takayuki, et al.
Publicado: (2023)

Should We Continue or Discontinue Inflammatory Bowel Disease Medication in Patients With Coronavirus Disease 2019?
por: Hayashi, Yuki, et al.
Publicado: (2022)

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
por: Hisamatsu, Tadakazu, et al.
Publicado: (2013)

A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter
por: Umeno, Junji, et al.
Publicado: (2015)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease
por: Mori, Kiyoto, et al.
Publicado: (2018)

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial
por: Inoue, Nagamu, et al.
Publicado: (2017)

Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations
por: Matsuno, Yuichi, et al.
Publicado: (2019)

Utility of endoscopic transpapillary pancreatic cyst drainage for intraductal papillary mucinous neoplasm infection
por: Watanabe, Shunsuke, et al.
Publicado: (2021)

Management of common bile duct stones in a pregnant woman by percutaneous biliary drainage followed by elective endoscopic stone removal after delivery
por: Kambayashi, Komei, et al.
Publicado: (2022)

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
por: Hisamatsu, Tadakazu, et al.
Publicado: (2021)

Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis
por: Naganuma, Makoto, et al.
Publicado: (2016)

Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn’s disease
por: Umeno, Junji, et al.
Publicado: (2018)

Repeated Pancreatectomy for Metachronous Duodenal and Pancreatic Metastases of Renal Cell Carcinoma
por: Hata, Tatsuo, et al.
Publicado: (2013)

Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow
por: Hisamatsu, Tadakazu
Publicado: (2020)

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
por: Kakuta, Yoichi, et al.
Publicado: (2018)

Utilization of a new technology of 3D biliary CT for ERCP-related procedures: a case report
por: Toki, Masao, et al.
Publicado: (2020)

Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
por: Kobayashi, Taku, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ink4sdods6i2shun6jbi9g27lp